nference Completes $60M Series C to Accelerate and Expand Augmented Intelligence for Life Sciences
12/15/20, 11:14 AM
Location
cambridge
Money raised
$60 million
Round Type
series c
nference, which synthesizes the world's biomedical knowledge, announced completion of a $60 million Series C funding round led by Matrix Capital Management, along with Matrix Partners, Mayo Clinic Ventures and NTTVC.
Company Info
Location
cambridge, maryland, united states
Additional Info
Through its augmented intelligence nferXTM software platform, nference synthesizes exponentially growing storehouses of siloed biomedical knowledge into actionable insights. State-of-the-art neural networks are trained to deliver real-time, automated intelligence extracted from scientific, clinical, regulatory and commercial data sets. The platform supports a diverse set of applications across the life-sciences ecosystem. nference is headquartered in Cambridge, MA. Follow nference on LinkedIn and Twitter. Visit us at nference.ai.